Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript
Let's go ahead and get started. My name is Vikram Purohit. I'm one of the biotech analysts with the Morgan Stanley Research team, joined by my colleague from the EU Biopharma team, James Quigley. This is the fireside chat with Genmab.
Before we get started, I need to read a brief disclosure statement.
For all important disclosures, please see www.morganstanley.com/research disclosures. And for any questions, please see your Morgan Stanley sales representative.
With that, happy to have with me on the stage the team from Genmab. Thanks for joining us. Appreciate it.
James, I'll turn it over to you to kick off with some questions, and then we'll just go back and forth. And if there's questions from the audience, please let us know.
Questions & Answers
Excellent. I mean the biggest thing -- the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
